Literature DB >> 2460424

Detection of gangliosides as N-glycolylneuraminic acid-specific tumor-associated Hanganutziu-Deicher antigen in human retinoblastoma cells.

H Higashi1, T Sasabe, Y Fukui, M Maru, S Kato.   

Abstract

Gangliosides were shown to bear the tumor-associated N-glycolylneuraminic acid (NeuGc)-specific Hanganutziu-Deicher (HD) antigen expressed in human retinoblastoma cells. HD antigenic gangliosides were detected by thin-layer chromatography/enzyme-immunostaining using affinity-purified chicken antibody against GM3 containing NeuGc and horseradish peroxidase-conjugated anti-chicken IgG. One to four species of the antigenic gangliosides were detected from all of 4 cell lines, Y79, WERI-Rb1, TOTL1, and YK, as well as freshly cultured retinoblastoma cells and isolated tumor tissue. All cases contained GM3(NeuGc) as an HD antigen. No HD antigenic ganglioside was detected in normal retinal tissues by the same procedure.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2460424      PMCID: PMC5917607          DOI: 10.1111/j.1349-7006.1988.tb00060.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  16 in total

Review 1.  THE GANGLIOSIDES.

Authors:  L SVENNERHOLM
Journal:  J Lipid Res       Date:  1964-04       Impact factor: 5.922

2.  Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method.

Authors:  L SVENNERHOLM
Journal:  Biochim Biophys Acta       Date:  1957-06

3.  Detection of 4-O-acetyl-N-glycolylneuraminyl lactosylceramide as one of tumor-associated antigens in human colon cancer tissues by specific antibody.

Authors:  I Miyoshi; H Higashi; Y Hirabayashi; S Kato; M Naiki
Journal:  Mol Immunol       Date:  1986-06       Impact factor: 4.407

4.  Gangliosides of human, bovine and rabbit retina.

Authors:  M Holm; J E Månsson; M T Vanier; L Svennerholm
Journal:  Biochim Biophys Acta       Date:  1972-10-05

5.  Detection of antibodies to gangliosides in pathologic human sera. Serum-sickness type heterophile antibodies.

Authors:  M Naiki; H Higashi
Journal:  Adv Exp Med Biol       Date:  1980       Impact factor: 2.622

6.  Sensitive enzyme-immunostaining and densitometric determination on thin-layer chromatography of N-glycolylneuraminic acid-containing glycosphingolipids, Hanganutziu-Deicher antigens.

Authors:  H Higashi; Y Fukui; S Ueda; S Kato; Y Hirabayashi; M Matsumoto; M Naiki
Journal:  J Biochem       Date:  1984-05       Impact factor: 3.387

7.  Specificities of human heterophilic Hanganutziu and Deicher (H-D) antibodies and avian antisera against H-D antigen-active glycosphingolipids.

Authors:  Y Fujii; H Higashi; K Ikuta; S Kato; M Naiki
Journal:  Mol Immunol       Date:  1982-01       Impact factor: 4.407

8.  Characterization of N-glycolylneuraminic acid-containing gangliosides as tumor-associated Hanganutziu-Deicher antigen in human colon cancer.

Authors:  H Higashi; Y Hirabayashi; Y Fukui; M Naiki; M Matsumoto; S Ueda; S Kato
Journal:  Cancer Res       Date:  1985-08       Impact factor: 12.701

9.  Characterization of N-glycolyneuraminic acid-containing glycosphingolipids from a Marek's disease lymphoma-derived chicken cell line, MSB1, as tumor-associated heterophile Hanganutziu-Deicher antigens.

Authors:  H Higashi; K Ikuta; S Ueda; S Kato; Y Hirabayashi; M Matsumoto; M Naiki
Journal:  J Biochem       Date:  1984-03       Impact factor: 3.387

10.  Tumor-associated expression of glycosphingolipid Hanganutziu-Deicher antigen in human cancers.

Authors:  H Higashi; Y Nishi; Y Fukui; K Ikuta; S Ueda; S Kato; M Fujita; Y Nakano; T Taguchi; S Sakai
Journal:  Gan       Date:  1984-11
View more
  12 in total

Review 1.  Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy.

Authors:  L G Durrant; P Noble; I Spendlove
Journal:  Clin Exp Immunol       Date:  2012-02       Impact factor: 4.330

Review 2.  Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense.

Authors:  Kayluz Frias Boligan; Circe Mesa; Luis Enrique Fernandez; Stephan von Gunten
Journal:  Cell Mol Life Sci       Date:  2014-12-07       Impact factor: 9.261

3.  Immunohistochemical Reactivity of the 14F7 Monoclonal Antibody Raised against N-Glycolyl GM3 Ganglioside in Some Benign and Malignant Skin Neoplasms.

Authors:  Rancés Blanco; Enrique Rengifo; Charles E Rengifo; Mercedes Cedeño; Milagros Frómeta; Adriana Carr
Journal:  ISRN Dermatol       Date:  2011-04-10

Review 4.  Involvement of a non-human sialic Acid in human cancer.

Authors:  Annie N Samraj; Heinz Läubli; Nissi Varki; Ajit Varki
Journal:  Front Oncol       Date:  2014-02-19       Impact factor: 6.244

5.  Nontypeable Haemophilus influenzae Has Evolved Preferential Use of N-Acetylneuraminic Acid as a Host Adaptation.

Authors:  Preston S K Ng; Christopher J Day; John M Atack; Lauren E Hartley-Tassell; Linda E Winter; Tal Marshanski; Vered Padler-Karavani; Ajit Varki; Stephen J Barenkamp; Michael A Apicella; Michael P Jennings
Journal:  mBio       Date:  2019-05-07       Impact factor: 7.867

6.  Antitumor effects of the GM3(Neu5Gc) ganglioside-specific humanized antibody 14F7hT against Cmah-transfected cancer cells.

Authors:  Denise Dorvignit; Kayluz F Boligan; Ernesto Relova-Hernández; Marilyn Clavell; Armando López; Mayrel Labrada; Hans-Uwe Simon; Alejandro López-Requena; Circe Mesa; Stephan von Gunten
Journal:  Sci Rep       Date:  2019-07-09       Impact factor: 4.379

7.  Sensitive and specific detection of the non-human sialic Acid N-glycolylneuraminic acid in human tissues and biotherapeutic products.

Authors:  Sandra L Diaz; Vered Padler-Karavani; Darius Ghaderi; Nancy Hurtado-Ziola; Hai Yu; Xi Chen; Els C M Brinkman-Van der Linden; Ajit Varki; Nissi M Varki
Journal:  PLoS One       Date:  2009-01-21       Impact factor: 3.240

Review 8.  Exploration of the Sialic Acid World.

Authors:  Roland Schauer; Johannis P Kamerling
Journal:  Adv Carbohydr Chem Biochem       Date:  2018-11-28       Impact factor: 12.200

9.  Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides - preclinical and clinical data.

Authors:  Ana M Vázquez; Ana M Hernández; Amparo Macías; Enrique Montero; Daniel E Gómez; Daniel F Alonso; Mariano R Gabri; Roberto E Gómez
Journal:  Front Oncol       Date:  2012-10-23       Impact factor: 6.244

10.  Generation and characterization of a IgG monoclonal antibody specific for GM3 (NeuGc) ganglioside by immunizing β3Gn-T5 knockout mice.

Authors:  Dongwei He; Xiaoyan Fan; Boyi Liu; Yiqing Tian; Xiangmei Zhang; Lin Kang; Yan Tai; Shuzhen Liu; Qian Wang; Qingxia Li; Jianhui Cai
Journal:  Sci Rep       Date:  2018-02-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.